CUP BIOPSY FORCEPS 220130

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,l report with the FDA on 2020-01-20 for CUP BIOPSY FORCEPS 220130 manufactured by Cook Inc.

Event Text Entries

[188657055] Common name/procode: endoscopic grasping/cutting instrument, non-powered; ocz. (b)(4). This report includes information known at this time. A follow up report will be submitted should additional relevant information become available.
Patient Sequence No: 1, Text Type: N, H10


[188657056] As reported in literature: taguchi et al. 2017. Optimizing rna extraction of renal papilla biopsy tissue in kidney stone formers: a new methodology for genomic study. This was a prospective multicenter study conducted at four institutions located in japan and the united states. During the study period between september 2014 and august 2016, we included patients between 18 and 80 years of age with upper urinary tract stones requiring urs or pcnl procedures. A total of 90 renal papilla tissue specimens from 49 patients. "we obtained renal papillary tissue from upper and/or middle calyces using either 3f biopsy forceps (piranha , boston scientific; cup biopsy forceps (patient identifier 290203 and this report), cook medical inc) or bigopsy backloading biopsy forceps (patient identifier 289267) (cook medical inc). " 4 of 19 biopsy patients experienced perioperative complications in matched pair comparison between flexible ureteroscopy with & without biopsy. Authors did not identify what the adverse events were, so it is not possible to determine which devices were used in the cases in which the patient experienced an adverse event. Events per the? Perioperative complications? These are graded? I have pulled the grading also underneath; 1 patient grade 1? No intervention, 2 patients grade 2 pharmacological treatment, 1 patient grade 3b intervention under general anaesthesia. 4 of 16 biopsy patients experienced perioperative complications in matched pair comparison between percutaneous nephrolithotomy with and without biopsy. In table 4 in the biopsy group 3 patients had grade 1 perioperative complication? No intervention, and 1 patient has grade 2? Pharmacological treatment. The clavien- dindo classification is as follows: grade i any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside. Grade ii requiring pharmacological treatment with drugs other than such allowed for grade i complications. Blood transfusionsand total parenteral nutritionare also included. Grade iii: requiring surgical, endoscopic or radiological intervention, iiia: intervention not under general anesthesia, iiib: intervention under general anesthesia. Grade iv: life-threatening complication (including cns complications)* requiring ic/icu-management: iva: single organ dysfunction (including dialysis), ivb: multiorgandysfunction. This file is being created to capture the 8 perioperative complications that were observed within the ureteroscopy & percutaneous nephrolithotomy group. As it cannot be confirmed what device was used, this file is conservatively being created for cook cup biopsy forceps. As this literature was carried out in the us and japan- two files have been created to capture each location as an exact location cannot be confirmed. This case reports potential case(s) occurring in the japan. Patient identifier (b)(6) reports potential case(s) occurring in the us.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1820334-2020-00157
MDR Report Key9607281
Report SourceFOREIGN,HEALTH PROFESSIONAL,L
Date Received2020-01-20
Date of Report2020-03-26
Date Mfgr Received2020-03-24
Date Added to Maude2020-01-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS. JENNIFER CANADA
Manufacturer Street750 DANIELS WAY
Manufacturer CityBLOOMINGTON IN 47404
Manufacturer CountryUS
Manufacturer Postal47404
Manufacturer Phone8123392235
Manufacturer G1COOK INC
Manufacturer Street750 DANIELS WAY
Manufacturer CityBLOOMINGTON IN 47404
Manufacturer CountryUS
Manufacturer Postal Code47404
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCUP BIOPSY FORCEPS
Product CodeOCZ
Date Received2020-01-20
Catalog Number220130
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCOOK INC
Manufacturer Address750 DANIELS WAY BLOOMINGTON IN 47404 US 47404


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-01-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.